The Director-General of Foreign Trade(DGFT) vide Public Notice No. 01/2015-20 dated April 04, 2022, has extended the date for implementation of the Track and Trace system for export of drug formulations w.r.t. maintaining the Parent-Child relationship in packaging levels and its uploading on Central Portal for both SSI and non-SSI manufactured drugs till March 31, 2023.
The notification said, “In exercise of the powers conferred under Paragraph 2.04 of the Foreign Trade Policy, 2015-20, as amended from time to time, the Director-General of Foreign Trade hereby amends Para 2.90A of Handbook of Procedure- 2015-20, as notified vide Public Notice No. 43/2015-20 dated December 05, 2017, read with Public Notice No. 52 / 2015-20 dated January 05, 2016, Public Notice No. 05/2015-20 dated May 09, 2018, Public Notice No. 43/2015- 2020 dated November 01, 2018, Public Notice No. 16/2015- 2020 dated July 04, 2019, Public Notice No. 66/2015- 2020 dated March 30, 2019, Public Notice No. 16/2015-2020 dated September 22, 2020, and Public Notice No. 46/2015-20 dated March 31, 2021, on laying down the procedure for implementation of the Track and Trace system for export consignments of drug formulations.”
The date for implementation of the Track and Trace system for export of drug formulations with respect to maintaining the Parent-Child relationship in packaging levels and its uploading on the Central Portal has been extended up to 31.3.2023 for both SSI and non-SSI manufactured drugs.
Subscribe Taxscan Premium to view the JudgmentSupport our journalism by subscribing to Taxscan AdFree. Follow us on Telegram for quick updates.
